"Cor et Vasa" . . "\u00DArove\u0148 sekund\u00E1rn\u00ED prevence ischemick\u00E9 choroby srde\u010Dn\u00ED u \u010Desk\u00FDch pacient\u016F ve studii EUROASPIRE III"@cs . "Mayer, O." . . "RIV/00023001:_____/08:00001734" . "CZ - \u010Cesk\u00E1 republika" . "The quality of secondary prevention of coronary heart disease in Czech patients in the EUROASPIRE III survey"@en . "The quality of secondary prevention of coronary heart disease in Czech patients in the EUROASPIRE III survey"@en . . "P(NR9333)" . . "Introduction: The main objectives of prevention are to reduce morbidity and mortality, and to improve quality of life. Aim: To determine, in patients with coronary heart disease, whether the treatment goals, as defined by current guidelines on secondary prevention, are implemented in clinical practice. Methods: A total of 600 consecutive patients, men and women aged <= 80 years, were identified retrospectively with the following diagnoses: coronary artery bypass grafting, percutaneous transluminal coronary angioplasty or acute coronary syndrome. Data collection was based on a review of medical records and interview at least six months after hospital admission. Results: In total, 493 responders were interviewed. Among them, 21% were smokers, 37.3% were obese, 54% had raised blood pressure (>= 140/90 mmHg or 135/80 mmHg in those with diabetes), 56.8% had elevated LDL-cholesterol (>= 2.5 mmol/l) and 42% had overt diabetes (glucose > 7 mmol/l or antidiabetic treatment). At interview, 8"@en . . "401683" . . . "7"^^ . "RIV/00023001:_____/08:00001734!RIV09-MZ0-00023001" . "4"^^ . . "0010-8650" . "B\u011Blohoubek, Ji\u0159\u00ED" . "4" . "Patraulea, M." . "\u00DAvod: Z\u00E1kladn\u00EDm deklarovan\u00FDm c\u00EDlem kardiovaskul\u00E1rn\u00ED prevence je sn\u00ED\u017Een\u00ED mortality a morbidity a zlep\u0161en\u00ED kvality \u017Eivota pacient\u016F. C\u00EDl: Stanovit, nakolik jsou do praxe implementov\u00E1ny l\u00E9\u010Debn\u00E9 c\u00EDle definovan\u00E9 sou\u010Dasn\u011B platn\u00FDmi Doporu\u010Den\u00EDmi pro sekund\u00E1rn\u00ED prevenci ischemick\u00E9 choroby srde\u010Dn\u00ED (ICHS). Metoda: Konsekutivn\u011B a retrospektivn\u011B bylo vybr\u00E1no 600 pacient\u016F, mu\u017E\u016F a \u017Een ve v\u011Bku <= 80 let, hospitalizovan\u00FDch pro n\u011Bkterou z n\u00E1sleduj\u00EDc\u00ED diagn\u00F3z: elektivn\u00ED \u010Di emergentn\u00ED koron\u00E1rn\u00ED bypass \u010Di perkut\u00E1nn\u00ED koron\u00E1rn\u00ED angioplastika nebo akutn\u00ED koron\u00E1rn\u00ED syndrom. Sb\u011Br \u00FAdaj\u016F byl proveden na z\u00E1klad\u011B chorobopis\u016F s n\u00E1sledn\u00FDm vy\u0161et\u0159en\u00EDm respondent\u016F minim\u00E1ln\u011B \u0161est m\u011Bs\u00EDc\u016F pro p\u0159ijet\u00ED k hospitalizaci V\u00FDsledky: Celkem bylo vy\u0161et\u0159eno 493 respondent\u016F. Z nich 21 % byli aktivn\u00ED ku\u0159\u00E1ci, 37,3 % pacient\u016F bylo ob\u00E9zn\u00EDch, 54 % m\u011Blo neadekv\u00E1tn\u011B zv\u00FD\u0161en\u00FD krevn\u00ED tlak (>= 140/90 mm Hg nebo >= 135/80 mm Hg u diabetik\u016F), 56,8 % m\u011Blo zv\u00FD\u0161en\u00FD LDL-cholesterol (>= 2,5 mmol/l) a 42 % vykazovalo manifestn\u00ED diabetes (glykemie"@cs . "Rosolov\u00E1, H." . "\u00DArove\u0148 sekund\u00E1rn\u00ED prevence ischemick\u00E9 choroby srde\u010Dn\u00ED u \u010Desk\u00FDch pacient\u016F ve studii EUROASPIRE III"@cs . "secondary prevention; guidelines; EUROASPIRE III"@en . "\u0160imon, J." . . "Jeschke, J." . "50" . . . "\u00DArove\u0148 sekund\u00E1rn\u00ED prevence ischemick\u00E9 choroby srde\u010Dn\u00ED u \u010Desk\u00FDch pacient\u016F ve studii EUROASPIRE III" . "10"^^ . "Galovcov\u00E1, Mark\u00E9ta" . "\u00DArove\u0148 sekund\u00E1rn\u00ED prevence ischemick\u00E9 choroby srde\u010Dn\u00ED u \u010Desk\u00FDch pacient\u016F ve studii EUROASPIRE III" . . . "C\u00EDfkov\u00E1, Renata" . . . "Hrbkov\u00E1, J." . . "\u00DAvod: Z\u00E1kladn\u00EDm deklarovan\u00FDm c\u00EDlem kardiovaskul\u00E1rn\u00ED prevence je sn\u00ED\u017Een\u00ED mortality a morbidity a zlep\u0161en\u00ED kvality \u017Eivota pacient\u016F. C\u00EDl: Stanovit, nakolik jsou do praxe implementov\u00E1ny l\u00E9\u010Debn\u00E9 c\u00EDle definovan\u00E9 sou\u010Dasn\u011B platn\u00FDmi Doporu\u010Den\u00EDmi pro sekund\u00E1rn\u00ED prevenci ischemick\u00E9 choroby srde\u010Dn\u00ED (ICHS). Metoda: Konsekutivn\u011B a retrospektivn\u011B bylo vybr\u00E1no 600 pacient\u016F, mu\u017E\u016F a \u017Een ve v\u011Bku <= 80 let, hospitalizovan\u00FDch pro n\u011Bkterou z n\u00E1sleduj\u00EDc\u00ED diagn\u00F3z: elektivn\u00ED \u010Di emergentn\u00ED koron\u00E1rn\u00ED bypass \u010Di perkut\u00E1nn\u00ED koron\u00E1rn\u00ED angioplastika nebo akutn\u00ED koron\u00E1rn\u00ED syndrom. Sb\u011Br \u00FAdaj\u016F byl proveden na z\u00E1klad\u011B chorobopis\u016F s n\u00E1sledn\u00FDm vy\u0161et\u0159en\u00EDm respondent\u016F minim\u00E1ln\u011B \u0161est m\u011Bs\u00EDc\u016F pro p\u0159ijet\u00ED k hospitalizaci V\u00FDsledky: Celkem bylo vy\u0161et\u0159eno 493 respondent\u016F. Z nich 21 % byli aktivn\u00ED ku\u0159\u00E1ci, 37,3 % pacient\u016F bylo ob\u00E9zn\u00EDch, 54 % m\u011Blo neadekv\u00E1tn\u011B zv\u00FD\u0161en\u00FD krevn\u00ED tlak (>= 140/90 mm Hg nebo >= 135/80 mm Hg u diabetik\u016F), 56,8 % m\u011Blo zv\u00FD\u0161en\u00FD LDL-cholesterol (>= 2,5 mmol/l) a 42 % vykazovalo manifestn\u00ED diabetes (glykemie" . . . "Bruthans, Jan" . "[C301159E9E37]" .